Pharmaceutical Processing

Bayer announced today that it opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility. The grand opening of the state-of-the-art facility follows a $44 million investment in 2022. Bayer says it reflects its commitment to providing self-care solutions to consumers across North America while advancing meaningful engagement with the local community. This facility in Myerstown…

Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment aims to ensure all key Novartis medicines for U.S. patients will be made in the U.S. Its financial commitment enables the company to expand on its current pharmaceutical manufacturing, research and technology…

BDD announced today that it opened a new 122-square-meter GMP manufacturing facility at BioCity near Glasgow. The company opened its facility after two years of development following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) last month. A £2 million funding round from existing investors facilitated the development of the state-of-the-art…

Ashland announced that it completed a $10 million expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil. The company plans to mark the occasion with a ribbon-cutting ceremony tomorrow, April 4. This investment significantly expands Ashland’s pharmaceutical footprint in the region and capabilities to meet increasing market demand for coated tablets in Latin America and…

Cell and gene therapy teams face unique challenges in scaling production while maintaining precision and compliance. Strategic automation enables seamless technology transfer, integration, and scalability—turning solutions to reduce complexity into a competitive advantage. Advanced therapeutics is one of the fastest growing areas in life sciences. Many of today’s most promising new treatments are cell and…

Qosina announced today that it entered into a collaboration with AdvantaPure to enhance its selection of solutions for pharmaceutical manufacturing. AdvantaPure, the high-purity products division of NewAge Industries, anticipates and satisfies the evolving needs of the pharmaceutical and biopharmaceutical manufacturing industries. As an official distribution partner for AdvantaPure, Qosina now expands its tubing portfolio with…

The buzz around AI in drug discovery often centers on generating new molecular ideas. But as computational chemists know, an in silico design is only valuable if it can be efficiently synthesized in the lab and is manufacturable after that. Merck KGaA, Darmstadt, Germany, with its roots in both chemistry (via Sigma-Aldrich) and life science…

Johnson & Johnson today announced it broke ground on a $2 billion biologics manufacturing facility in Wilson, N.C., a small portion of the company’s $55 billion U.S. investment initiative over the next four years. The 500,000 ft² facility will expand the company’s capacity to develop and produce advanced therapies for oncology, immunology and neurological diseases.…

Currax Pharmaceuticals today announced the FDA approved a second manufacturing site for its Contrave medication. The approval of the second site enhances the production capacity for the company’s oral weight loss medication, also marketed as Mysimba in Europe. Currax said it is investing in manufacturing and advancing clinical research. “At Currax, we are steadfast in…

Emergent BioSolutions announced today that it entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility. The company agreed to sell the plant to Syngene, a leading global CRDMO, for a total value of $36.5 million. The plant includes manufacturing, laboratory, warehousing and office space, plus multiple monoclonal antibody (mAbs) manufacturing lines. Syngene…